Endogenous material in brain inhibiting [3H]nicotine and [3H]acetylcholine binding
β Scribed by Dr. H. Sershen; M. E. A. Reith; A. Hashim; A. Lajtha
- Publisher
- John Wiley and Sons
- Year
- 1984
- Tongue
- English
- Weight
- 393 KB
- Volume
- 12
- Category
- Article
- ISSN
- 0360-4012
No coin nor oath required. For personal study only.
β¦ Synopsis
The supernatant obtained from mouse brain homogenates contains material that inhibits the saturable binding of [3H]nicotine in mouse cerebral cortex. This inhibitory material was further purified by heat denaturation, ultrafiltration through an Amicon PM-10 membrane filter, and gel chromatography on Sephadex G-10. The material inhibited the binding of [3HH]acetylcholine with the same potency as it did that of [3H]nicotine. It also had some affinity for the sites that specifically bind ['HID-Ala, D-Leu enkephalin, but had much lower affinity for the binding sites for [3H]quinuclidinyl benzilate (QNB), (3H]spiroperidol, [3H]naloxone, or ['Hlimipramine. Acid hydrolysis destroyed the activity. These preliminiary results suggest the presence in brain of "nicotinelike" substances, one of which may be the endogenous ligand for the sites that specifically bind [3H]ni~~tine.
π SIMILAR VOLUMES
## Abstract Competition by endogenous dopamine with the binding of D~2~ dopamine receptor ligands may be important in the interpretation of positron emission tomography (PET) neuroreceptor studies. PET studies with Nβmethylspiperone (NMSP) have revealed increased D~2~ dopamine receptors in schizoph